February 6, 2014
Hepatitis C (HCV) infection can be a confusing disease for patients without proper guidance from their care providers. Due to the complex nature of the virus, its effects on the body and our rapidly evolving treatment options, it can also be difficult for providers to answer questions in a way that resonates with their patients.
Fortunately, at TheBody.com -- TheBodyPRO.com's sister site for the general community -- answering patient questions is what we do. Whether they are concerned about transmission or want to know about managing and treating the disease, our resident hepatitis expert, Lynn E. Taylor, M.D., F.A.C.P., A.A.H.I.V.S., an assistant professor of medicine in the division of infectious diseases at Brown University and attending physician at the Miriam Hospital in Providence, R.I., is there to fill in the gaps.
Here are a collection of answers to some of the most frequently asked questions we see about HCV on TheBody.com. These Q&As provide the necessary context and information to help create a better-informed patient.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|No Increased Risk of Liver Cancer After Hepatitis C Treatment With Direct-Acting Antivirals|
|This Week in HIV Research: Another Person Possibly Cured of HIV; and Long-Acting Rilpivirine Suppresses HIV in Rectal Tissue|
|This Week in HIV Research: HIV-Related Inflammation May Be Irreversible; and Genetically Engineered T-Cells Resist HIV|
|How Close Are We to a Cure for HIV? A Q&A With HIV Cure Scientific Superstars|
|Dolutegravir and the Central Nervous System: A Top HIV Clinical Development of 2016|